Drug intelligence / Profile preview

Siheyi Shugan Capsule

Development stage: Unknown
Lead developer: Qinghai Jiumei Tibetan Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Siheyi Shugan Capsule is a traditional Tibetan medicine (TTM) developed and manufactured by Qinghai Jiumei Tibetan Medicine. It is an oral herbal formulation encapsulated for the treatment of liver and gallbladder-related conditions. In the context of Tibetan medicine, the formulation is designed to "soothe the liver" (疏肝), which typically involves regulating liver Qi, clearing heat, and resolving stagnation. It is indicated for conditions such as chronic hepatitis, cholecystitis, and liver pain. The product is approved by the National Medical Products Administration (NMPA) in China and is currently marketed as a pharmaceutical product.

Brand names: Jiumei
Other names: 四合一疏肝胶囊Siheyi Shugan Jiao NangSiheyi Shugan Capsules

Beyond the preview

Go deeper on Siheyi Shugan Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siheyi Shugan Capsule.

Explore the full profile